PAK4 inhibitor PF-03758309
Term · Oncology and biomedicine · MLC-T-ONC-015772
An orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity. PAK4 inhibitor PF-03758309 binds to PAK4, inhibiting PAK4 activity and cancer cell growth. PAK4, a serine/threonine kinase belonging to the p21-activated kinase (PAK) family, is often upregulated in a variety of cancer cell types and plays an important role in cancer cell motility, proliferation, and survival.
| Identifier | MLC-T-ONC-015772 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | p21-activated kinase 4 inhibitor PF-03758309 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015772",
"term": "PAK4 inhibitor PF-03758309",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity. PAK4 inhibitor PF-03758309 binds to PAK4, inhibiting PAK4 activity and cancer cell growth. PAK4, a serine/threonine kinase belonging to the p21-activated kinase (PAK) family, is often upregulated in a variety of cancer cell types and plays an important role in cancer cell motility, proliferation, and survival.",
"synonyms": [
"p21-activated kinase 4 inhibitor PF-03758309"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pak4-inhibitor-pf-03758309/"
}
Record 12,521 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.